Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases
O. Fedorov, Brian D. Marsden, Vanda Pogac̆ić, et al.
Proceedings of the National Academy of Sciences (2007) Vol. 104, Iss. 51, pp. 20523-20528
Open Access | Times Cited: 350

Showing 1-25 of 350 citing articles:

Selective inhibition of BET bromodomains
P. Filippakopoulos, Jun Qi, S. Picaud, et al.
Nature (2010) Vol. 468, Iss. 7327, pp. 1067-1073
Open Access | Times Cited: 3860
Targeting cancer with small molecule kinase inhibitors
Jianming Zhang, Priscilla L. Yang, Nathanael S. Gray
Nature reviews. Cancer (2008) Vol. 9, Iss. 1, pp. 28-39
Closed Access | Times Cited: 2460
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis, Jeremy P. Hunt, Sanna Herrgård, et al.
Nature Biotechnology (2011) Vol. 29, Iss. 11, pp. 1046-1051
Closed Access | Times Cited: 2071
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
Oliver Borst, Britta Walker, Patrick Münzer, et al.
Cellular Physiology and Biochemistry (2013) Vol. 31, Iss. 6, pp. 914-924
Open Access | Times Cited: 1840
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina, Rozbeh Jafari, Marina Ignatushchenko, et al.
Science (2013) Vol. 341, Iss. 6141, pp. 84-87
Closed Access | Times Cited: 1811
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari, Helena Almqvist, Hanna Axelsson, et al.
Nature Protocols (2014) Vol. 9, Iss. 9, pp. 2100-2122
Closed Access | Times Cited: 1153
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis, Sean Deacon, Karthik Devarajan, et al.
Nature Biotechnology (2011) Vol. 29, Iss. 11, pp. 1039-1045
Open Access | Times Cited: 859
Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Mikko Taipale, Irina Krykbaeva, Martina Koeva, et al.
Cell (2012) Vol. 150, Iss. 5, pp. 987-1001
Open Access | Times Cited: 802
Targeting the cancer kinome through polypharmacology
Zachary A. Knight, Henry J. Lin, Kevan M. Shokat
Nature reviews. Cancer (2010) Vol. 10, Iss. 2, pp. 130-137
Open Access | Times Cited: 648
Protein promiscuity and its implications for biotechnology
Irene Nobeli, Angelo D. Favia, Janet M. Thornton
Nature Biotechnology (2009) Vol. 27, Iss. 2, pp. 157-167
Closed Access | Times Cited: 480
Protein methyltransferases as a target class for drug discovery
Robert A. Copeland, Michael E. Solomon, Victoria M. Richon
Nature Reviews Drug Discovery (2009) Vol. 8, Iss. 9, pp. 724-732
Closed Access | Times Cited: 448
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
E. Wahlberg, T. Karlberg, E. Kouznetsova, et al.
Nature Biotechnology (2012) Vol. 30, Iss. 3, pp. 283-288
Closed Access | Times Cited: 444
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith, Stephen L. Wang, Saul Jaime‐Figueroa, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 443
Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis
Jing Tang, Agnieszka Szwajda, Sushil Kumar Shakyawar, et al.
Journal of Chemical Information and Modeling (2014) Vol. 54, Iss. 3, pp. 735-743
Closed Access | Times Cited: 436
PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
L. Brault, Christelle Gasser, Franz Bracher, et al.
Haematologica (2010) Vol. 95, Iss. 6, pp. 1004-1015
Open Access | Times Cited: 357
Comprehensive characterization of the Published Kinase Inhibitor Set
Jonathan M. Elkins, Vita Fedele, M. Szklarz, et al.
Nature Biotechnology (2015) Vol. 34, Iss. 1, pp. 95-103
Open Access | Times Cited: 325
High-throughput production of human proteins for crystallization: The SGC experience
P. Savitsky, James E. Bray, C.D.O. Cooper, et al.
Journal of Structural Biology (2010) Vol. 172, Iss. 1, pp. 3-13
Open Access | Times Cited: 325
The (un)targeted cancer kinome
O. Fedorov, Susanne Müller, Stefan Knapp
Nature Chemical Biology (2010) Vol. 6, Iss. 3, pp. 166-169
Closed Access | Times Cited: 308
Illuminating the dark phosphoproteome
Elise J. Needham, Benjamin L. Parker, Timur Burykin, et al.
Science Signaling (2019) Vol. 12, Iss. 565
Open Access | Times Cited: 299
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
Richard Morphy
Journal of Medicinal Chemistry (2009) Vol. 53, Iss. 4, pp. 1413-1437
Closed Access | Times Cited: 286
A Strategy for Modulation of Enzymes in the Ubiquitin System
Andreas Ernst, G.V. Avvakumov, Jiefei Tong, et al.
Science (2013) Vol. 339, Iss. 6119, pp. 590-595
Open Access | Times Cited: 285
KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space
Oscar P. J. van Linden, Albert J. Kooistra, Rob Leurs, et al.
Journal of Medicinal Chemistry (2013) Vol. 57, Iss. 2, pp. 249-277
Closed Access | Times Cited: 275
Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases
Tara L. Davis, John R. Walker, Valérie Campágna‐Slater, et al.
PLoS Biology (2010) Vol. 8, Iss. 7, pp. e1000439-e1000439
Open Access | Times Cited: 274
The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies
Daniel Martinez Molina, P. Nordlund
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 141-161
Open Access | Times Cited: 264
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
S. Picaud, David Da Costa, Angeliki Thanasopoulou, et al.
Cancer Research (2013) Vol. 73, Iss. 11, pp. 3336-3346
Open Access | Times Cited: 235
Page 1 - Next Page

Scroll to top